JD Supra13h
Biologics and Biosimilars Landscape 2024: IP, Policy, and Market Developments
Last year marked an all-time record of 18 Food and Drug Administration (FDA) biosimilar approvals, bringing the total number ...
ophthalmologytimes13h
UK MHRA issues approval for aflibercept biosimilar FYB203 (AHZANTIVE) from Formycon
FYB203, a biosimilar to aflibercept, received UK MHRA approval for multiple retinal conditions and will be marketed as ...
PharmiWeb17h
Global Retinal Biologics Market to Reach USD 41.92 Billion by 2028 at a 11.1% of CAGR
Retinal Biologics MarketThe Retinal Biologics Market generated USD 19.96 billion in revenue in 2021 and is projected to grow ...